Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy

The Lancet Neurology in conversation with

English - July 13, 2022 22:00 - 22 minutes - 15.8 MB
Life Sciences Science Education stroke alzheimer's epilepsy sleep cerebral multiple sclerosis Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies

Next Episode: Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy

Andreas Charidimou (Massachusetts General Hospital, Boston, MA, USA) discusses an international collaborative study that presents new Boston criteria for diagnosis of cerebral amyloid angiopathy; the Article is published in the August issue of The Lancet Neurology.

Read the full article:
The Boston criteria version 2.0 for cerebral amyloid angiopathy

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv